Impact of agitation in long-term care residents with dementia in the United States
- PMID: 34286877
- PMCID: PMC9291552
- DOI: 10.1002/gps.5604
Impact of agitation in long-term care residents with dementia in the United States
Abstract
Objectives: To describe characteristics and compare clinical outcomes including falls, fractures, infections, and neuropsychiatric symptoms (NPS) among long-term care residents with dementia with and without agitation.
Methods: A cross-sectional secondary analysis of administrative healthcare data was conducted whereby residents with dementia residing in a long-term care facility for ≥12 months were identified from the AnalytiCare LLC database (10/2010-06/2014) and were classified into mutually exclusive cohorts (Agitation Cohort or No-Agitation Cohort) based on available agitation-related symptoms. Entropy balancing was used to balance demographic and clinical characteristics between the two cohorts. The impact of agitation on clinical outcomes was compared between balanced cohorts using weighted logistic regression models.
Results: The study included 6,265 long-term care residents with dementia among whom, 3,313 were included in the Agitation Cohort and 2,952 in the No-Agitation Cohort. Prior to balancing, residents in the Agitation Cohort had greater dementia-related cognitive impairment and clinical manifestations compared to the No-Agitation Cohort. After balancing, residents with and without agitation, respectively, received a median of five and four distinct types of medications (including antipsychotics). Further, compared to residents without agitation, those with agitation were significantly more likely to have a recorded fall (OR = 1.58), fracture (OR = 1.29), infection (OR = 1.18), and other NPS (OR = 2.11).
Conclusions: Agitation in long-term care residents with dementia was associated with numerically higher medication use and an increased likelihood of experiencing falls, fractures, infections, and additional NPS compared to residents without agitation, highlighting the unmet need for effective management of agitation symptoms in this population.
Keywords: agitation; dementia; falls; fractures; infections; long-term care; medication use; neuropsychiatric symptoms.
© 2021 Otsuka Pharmaceutical Development and Commercialization Inc. International Journal of Geriatric Psychiatry published by John Wiley & Sons Ltd.
Conflict of interest statement
Patrick Gagnon‐Sanschagrin, Martin Cloutier, Mikhaïl Davidson, Elizabeth Serra, and Annie Guérin are employees of Analysis Group, Inc., a consulting company that has received consultancy fees from Otsuka Pharmaceutical Development and Commercialization, Inc., to conduct this study. Myrlene Sanon Aigbogun was an employee of Otsuka Pharmaceutical Development and Commercialization, Inc. at the time the study was conducted. Ross A. Baker is an employee of Otsuka Pharmaceutical Development and Commercialization, Inc. Christy R. Houle is an employee of Lundbeck Pharmaceuticals.
Figures




References
-
- Alzheimer's Association . Alzheimer's disease facts and figures. Alzheimer's Dementia. 2018;14(3):367‐429.
-
- Sanon Aigbogun S, Jones E, Husbands J, et al. Behavioral symptoms and disturbances in dementia: a highly prevalent condition. AAIC. 2019;2019.
Publication types
MeSH terms
LinkOut - more resources
Medical